Literature DB >> 15963710

Working with NKT cells--pitfalls and practicalities.

Stuart P Berzins1, Mark J Smyth, Dale I Godfrey.   

Abstract

Our understanding of NKT cells has been rapidly advancing over recent years, with many research groups studying how these cells behave and how they can be manipulated to prevent disease. Although good progress has been made, a difficulty is the lack of a clear consensus about how to assay, or even identify, NKT cells. The different approaches have been an ongoing source of uncertainty about the biological behaviour and function of NKT cells and have complicated efforts to define their role in immunity. An important step towards reaching agreement on the behaviour of NKT cells is to have a clear appreciation of the advantages and disadvantages of the different approaches that are employed in this field of study. This should help determine the most appropriate ways to investigate NKT cell function, thus bringing us closer to successfully exploiting these cells in the treatment of human diseases.

Entities:  

Mesh:

Year:  2005        PMID: 15963710     DOI: 10.1016/j.coi.2005.05.012

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  16 in total

1.  Engagement of glycosylphosphatidylinositol-anchored proteins results in enhanced mouse and human invariant natural killer T cell responses.

Authors:  Lisa A Mannik; Ian Chin-Yee; Shayan Sharif; Luc Van Kaer; Terry L Delovitch; S M Mansour Haeryfar
Journal:  Immunology       Date:  2010-11-11       Impact factor: 7.397

2.  Hepatocellular cancer-derived alpha fetoprotein uptake reduces CD1 molecules on monocyte-derived dendritic cells.

Authors:  Chunlei Li; Baobao Song; Patricia M Santos; Lisa H Butterfield
Journal:  Cell Immunol       Date:  2018-11-01       Impact factor: 4.868

3.  Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease.

Authors:  Cheng-Fu Xu; Chao-Hui Yu; You-Ming Li; Lei Xu; Juan Du; Zhe Shen
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

4.  Ex-vivo analysis of human natural killer T cells demonstrates heterogeneity between tissues and within established CD4(+) and CD4(-) subsets.

Authors:  A C Chan; E Leeansyah; A Cochrane; Y d'Udekem d'Acoz; D Mittag; L C Harrison; D I Godfrey; S P Berzins
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

5.  Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders.

Authors:  E Zigmond; S Preston; O Pappo; G Lalazar; M Margalit; Z Shalev; L Zolotarov; D Friedman; R Alper; Y Ilan
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

Review 6.  Orchestration of invariant natural killer T cell development by E and Id proteins.

Authors:  Sumedha Roy; Yuan Zhuang
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

7.  A semi-invariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties.

Authors:  Adam P Uldrich; Onisha Patel; Garth Cameron; Daniel G Pellicci; E Bridie Day; Lucy C Sullivan; Konstantinos Kyparissoudis; Lars Kjer-Nielsen; Julian P Vivian; Benjamin Cao; Andrew G Brooks; Spencer J Williams; Petr Illarionov; Gurdyal S Besra; Stephen J Turner; Steven A Porcelli; James McCluskey; Mark J Smyth; Jamie Rossjohn; Dale I Godfrey
Journal:  Nat Immunol       Date:  2011-06-12       Impact factor: 25.606

Review 8.  Presumed guilty: natural killer T cell defects and human disease.

Authors:  Stuart P Berzins; Mark J Smyth; Alan G Baxter
Journal:  Nat Rev Immunol       Date:  2011-02       Impact factor: 53.106

9.  Beta2-microglobulin-dependent bacterial clearance and survival during murine Klebsiella pneumoniae bacteremia.

Authors:  Anna L Cogen; Thomas A Moore
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

10.  CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes.

Authors:  Patricia Barral; Paolo Polzella; Andreas Bruckbauer; Nico van Rooijen; Gurdyal S Besra; Vincenzo Cerundolo; Facundo D Batista
Journal:  Nat Immunol       Date:  2010-03-14       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.